10 likes | 10 Views
Factors attributing to the growth of the bioinformatics market include rising investment and funding for the R&D activities associated with genomics and proteomics; increasing demand for nucleic acid and protein sequencing; and increasing application in blockchain technology and cloud computing.
E N D
Future Outlook of Bioinformatics Market by 2031 According to the deep-dive market assessment study conducted by Growth+Reports, the global bioinformatics market was pegged at ~US$ 22.24 billion in 2020. The market is expected to witness a CAGR of ~14.2% from 2021 to 2031. Factors attributing to the growth of the bioinformatics market include rising investment and funding for the R&D activities associated with genomics and proteomics; increasing demand for nucleic acid and protein sequencing; and increasing application in blockchain technology and cloud computing. However, factors such as lack of well-defined standards and challenges in managing & handling large volumes of data, and the dearth of skilled professionals are likely to restrain the market growth to a certain extent. To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/bioinformatics-market/7618 As the speed of data generation is increasing, the management of large volumes of data is becoming a challenge. Moreover, the shortage of skilled bioinformatics professionals, different formats for data storage, and the lack of user-friendly tools at lower prices are some of the challenges faced by the bioinformatics market. Some of the prominent players operating in the Bioinformatics market includes: - •Thermo Fisher Scientific •Illumina •QIAGEN, PerkinElmer •Agilent Technologies •Eurofins Genomics LLC •DNASTAR •Biomax Informatics AG •Partek •Incorporated •Psomagen •among others. Browse the full report now: https://growthplusreports.com/report/bioinformatics-market/7618 About Us: Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.